Reporting of an adverse event, a product quality problem or a product use error

Please call
Dr Gabriel Cozma (Head of Pharmacovigilance Unit): +41 79 337 76 91 or
Stéphane Michaut (Pharmacovigilance Coordinator) : +41 79 779 04 33
and send a fax to +41 22 783 11 80, stating your name, address, phone number and name of the product.

OM PHARMA main contacts

PRESIDENT: Christophe Ricard

JOINT DEPUTY MANAGING DIRECTORS: Philippe Meuwly / David Harar-Kenzey

INFORMATION AND COMMUNICATIONS: Philippe Meuwly

STRATEGIC PLANNING: Philippe Meuwly

CONTROLLING: Winston Kenzey

BUSINESS DEVELOPMENT: Philippe Meuwly
• Business development biological products : Philippe Meuwly a.i.
• Business development synthetic products : Margaret Bergerioux
• Licensing-out R&D products : David Limal

HUMAN RESOURCES: Christian Pruneaud

QUALITY, ENVIRONMENT, SECURITY: Philippe Jaccard

RESEARCH & DEVELOPMENT: Jacques Bauer

MEDICAL & REGULATORY / PHARMACOVIGILANCE: Gabriel Cozma

COMMERCIAL
International Operations: Reto Baumann
• Export Europe: Myrta Keller
• Export Latin America: Laurent Taglialatela
• Export Middle East, Far East and Africa: Nicolas Ghosn

International Marketing & Sales: Eduardo Barriga-Garcia
• Marketing & Sales Europe: Johann Frain
• Marketing & Sales Latin America: Pierre Pialoux
• Marketing & Sales Middle East, Asia and Africa: Siham Azi
• International Marketing Manager : François Boualavong
• Medical Marketing Manager : Cherif Benguerba

PRODUCTION: Gilbert Fumex

FINANCE: David Harar-Kenzey

ADMINISTRATION: David Harar-Kenzey

OM PHARMA GROUP
• OM PHARMA S.A. (Portugal): Antonio Jordao
• OM PHARMA S.A. (Peru): Antonio Ciudad